论文部分内容阅读
目的:探讨内镜注射硬化剂治疗晚期前列腺癌和膀胱癌引起的膀胱内顽固性出血的疗效。方法:对15例患者经膀胱镜检查明确出血部位,在出血灶内和出血灶周围联合注射聚桂醇治疗晚期前列腺癌和膀胱癌引起的膀胱内顽固性出血。结果:15例患者治疗后1周左右血尿停止,膀胱镜复查肿瘤体积均有不同程度缩小。结论:内镜注射硬化剂治疗晚期前列腺癌和膀胱癌能明显止血,延长生存时间,改善生活质量,无并发症,是一种简单、高效、微创的治疗新方法。
Objective: To investigate the efficacy of endoscopic injection sclerotherapy in refractory intravesical hemorrhage caused by advanced prostate cancer and bladder cancer. Methods: Fifteen patients underwent cystoscopy to identify the site of hemorrhage. Intravenous hemorrhage and perihematoma injection of lauromacyl alcohol were used to treat refractory intravesical hemorrhage caused by advanced prostate cancer and bladder cancer. Results: After 15 weeks of treatment, the hematuria stopped and cystoscopy was used to check the tumor volume to varying degrees. Conclusion: Endoscopic injection of sclerotherapy for advanced prostate cancer and bladder cancer can significantly hemostasis, prolong survival time, improve quality of life and no complications. It is a simple, efficient and minimally invasive treatment.